These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38525008)
1. IL-12-Overexpressed Nanoparticles Suppress the Proliferation of Melanoma Through Inducing ICD and Activating DC, CD8 Shen HH; Peng JF; Wang RR; Wang PY; Zhang JX; Sun HF; Liang Y; Li YM; Xue JN; Li YJ; Sun GB; Xie SY Int J Nanomedicine; 2024; 19():2755-2772. PubMed ID: 38525008 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy]. Lin X; Mao D; Bai R Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246 [TBL] [Abstract][Full Text] [Related]
3. [Immunoregulatory effects of periplocin from Cortex Periplocae in tumor-bearing mice]. Zhang J; Shan BE; Li QM; Zhang C; Zhao RN; Ai J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Oct; 25(10):887-90. PubMed ID: 19811733 [TBL] [Abstract][Full Text] [Related]
4. The copper (II) complex of salicylate phenanthroline induces immunogenic cell death of colorectal cancer cells through inducing endoplasmic reticulum stress. Chen M; Wang D; Fan L; Niu D; Xu J; Liu Y; Liu Y Int Immunopharmacol; 2024 May; 132():111980. PubMed ID: 38555819 [TBL] [Abstract][Full Text] [Related]
5. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer. Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946 [TBL] [Abstract][Full Text] [Related]
6. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil]. Chi PD; Li L; Fan YY; Wu CY Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537 [TBL] [Abstract][Full Text] [Related]
7. Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo. Sha X; Xu X; Liao S; Chen H; Rui W Exp Cell Res; 2022 Jan; 410(1):112948. PubMed ID: 34826423 [TBL] [Abstract][Full Text] [Related]
8. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer]. Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667 [No Abstract] [Full Text] [Related]
9. Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway. Chen Y; Wang L; Chen N; Tang G Transl Oncol; 2024 Sep; 47():102052. PubMed ID: 38981246 [TBL] [Abstract][Full Text] [Related]
10. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects. Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975 [TBL] [Abstract][Full Text] [Related]
11. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner. Werthmöller N; Frey B; Wunderlich R; Fietkau R; Gaipl US Cell Death Dis; 2015 May; 6(5):e1761. PubMed ID: 25973681 [TBL] [Abstract][Full Text] [Related]
12. Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors. Kim MT; Richer MJ; Gross BP; Norian LA; Badovinac VP; Harty JT J Immunol; 2015 Nov; 195(9):4537-44. PubMed ID: 26408669 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model. Yuan CH; Yang XQ; Zhu CL; Liu SP; Wang BC; Wang FB Asian Pac J Cancer Prev; 2014; 15(1):265-71. PubMed ID: 24528037 [TBL] [Abstract][Full Text] [Related]
14. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109 [TBL] [Abstract][Full Text] [Related]
15. Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8 Shan CK; Du YB; Zhai XT; Wang YX; Li Y; Gong JH; Ge ZJ; Liu XJ; Zhen YS Cancer Chemother Pharmacol; 2021 Mar; 87(3):425-436. PubMed ID: 33388950 [TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin Induces Immunogenic Cell Death in Human and Murine Laryngeal Cancer. Wang J; Zhang H; Yin X; Bian Y J Oncol; 2022; 2022():3760766. PubMed ID: 36131787 [TBL] [Abstract][Full Text] [Related]
17. [Interleukin-12 over-expression in malignant melanoma B16 cells reduces programmed death-1 expression on T cells in mice with immune reconstitution]. Liu Y; Xu H; Lai N; Yang Z; Kang S Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):856-863. PubMed ID: 32895201 [TBL] [Abstract][Full Text] [Related]
18. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets. Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559 [TBL] [Abstract][Full Text] [Related]
19. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity. Sethuraman SN; Singh MP; Patil G; Li S; Fiering S; Hoopes PJ; Guha C; Malayer J; Ranjan A Theranostics; 2020; 10(8):3397-3412. PubMed ID: 32206098 [No Abstract] [Full Text] [Related]
20. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10. Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]